1 (31e1e1b4 0738 446c 8861 Af5c49d08b54 01)
This is a table showing the treatment-emergent adverse reactions observed with a frequency of more than 2% and greater than placebo for Major Depressive Disorder. The table compares the percentage of Escitalopram Oxalate (N=715) and Placebo (N=592) in various disorders such as Autonomic Nervous System Disorders, Central and Peripheral Nervous System, Intestinal Disorders, General, Psychiatric Disorders Respiratory System Disorders, and Urogenital disorders. The adverse reactions include dry mouth, sweating increased, constipation, diarrhea, decreased libido, ejaculation disorder, anorgasmia among others.*